1. Home
  2. GSIT vs PRQR Comparison

GSIT vs PRQR Comparison

Compare GSIT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSI Technology

GSIT

GSI Technology

HOLD

Current Price

$9.77

Market Cap

314.5M

Sector

Technology

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.76

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSIT
PRQR
Founded
1995
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
314.5M
166.4M
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
GSIT
PRQR
Price
$9.77
$1.76
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$7.67
AVG Volume (30 Days)
664.0K
285.6K
Earning Date
04-30-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
47.50
N/A
EPS
N/A
N/A
Revenue
$20,518,000.00
N/A
Revenue This Year
N/A
$11.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.62
$1.08
52 Week High
$18.14
$3.10

Technical Indicators

Market Signals
Indicator
GSIT
PRQR
Relative Strength Index (RSI) 68.95 54.26
Support Level $5.31 $1.65
Resistance Level $18.14 $1.80
Average True Range (ATR) 0.74 0.10
MACD 0.15 0.03
Stochastic Oscillator 94.62 53.00

Price Performance

Historical Comparison
GSIT
PRQR

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: